#VisualAbstract: Bedaquiline-linezolid regimen noninferior to standard treatment for tuberculosis
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior...
Read MoreMar 24, 2023
1. In this randomized control trial, an eight-week bedaquiline-linezolid regimen was noninferior...
Read MoreMar 20, 2023
Click to read this study in JAMA Surgery.
Read MoreMar 20, 2023
Click to read this study in The Lancet Oncology.
Read MoreMar 20, 2023
1. Patients allocated to the sotorasib group reported increased progression-free survival compared...
Read MoreMar 20, 2023
1. In this randomized clinical trial, among 167 older adults with frailty and non-ST segment...
Read MoreMar 10, 2023
Click to read this study in The Lancet Oncology.
Read MoreMar 10, 2023
Click to read this study in JAMA Network Open.
Read MoreMar 10, 2023
1. Event-free survival at 2 years was longer in the neoadjuvant-adjuvant group vs the...
Read MoreMar 10, 2023
1. The 5-year disease-free survival, overall survival, and recurrence rates were similar in both...
Read MoreFeb 21, 2023
Click here to read this study in NEJM
Read MoreFeb 16, 2023
1. In this randomized control trial of knee osteoarthritis patients, there was no significant...
Read MoreFeb 15, 2023
1. Quality of life at one year was improved in patients with heart failure with preserved ejection...
Read MoreFeb 13, 2023
Click to read this study in The Lancet Oncology.
Read MoreFeb 3, 2023
1. In patients with untreated paroxysmal atrial fibrillation, catheter ablation was associated...
Read MoreFeb 2, 2023
1. In this randomized clinical trial, there were no differences in mortality, pulmonary embolism,...
Read MoreJan 31, 2023
Click to read this study in The Lancet Oncology.
Read MoreJan 27, 2023
1. In a randomized clinical trial, internet-delivered parent-child interaction therapy (iPCIT)...
Read MoreJan 27, 2023
Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with...
Read MoreJan 25, 2023
Click to read this study in JAMA Oncology.
Read MoreJan 24, 2023
Click to read this study in JAMA Network Open.
Read More